Tubiano, Marilou Q.

HRN: 25-60-71  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/03/2024
08/10/2024
IVT
600mg
Q6
Nonhealing Wound, Both Feet
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: